Sainz de la Cuesta R, Eichhorn J H, Rice L W, Fuller A F, Nikrui N, Goff B A
Vincent Memorial Gynecologic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Gynecol Oncol. 1996 Feb;60(2):238-44. doi: 10.1006/gyno.1996.0032.
Between 1975 and 1990, 79 patients with Stage I epithelial ovarian cancer were treated at Massachusetts General Hospital. Patients were identified from the tumor registry and medical records were retrospectively reviewed. Pathological slides were evaluated for the presence of endometriosis, specifically looking for malignancy arising in endometriosis. Evidence of endometriosis was found in 22 of the 79 cases (28%). In the 23 cases of endometrioid histology, 9 cases (39%) were associated with endometriosis and, in the 17 cases of clear cell tumors, 7 (41%) were associated with endometriosis. All 8 cases of mixed histology had clear cell and/or endometrioid components and 4 cases (50%) were associated with endometriosis. Endometrioid adenocarcinoma accounted for 41% of the tumors associated with endometriosis, clear cell carcinoma 31%, mixed (endometrioid and/or clear cell types) 18%, and other types 9%. Among the 22 patients with associated endometriosis, we found 7 carcinomas (32%) arising in endometriosis. In these 7 cases a spectrum of benign and atypical endometriosis with a transition to clear cell or endometrioid adenocarcinoma were identified. These premalignant changes were characterized by cytologic atypia and architectural proliferation. Endometriosis was frequently encountered among patients with Stage I epithelial ovarian cancer of endometrioid and clear cell histologies. Endometriosis may play a role in the pathogenesis of some early stage malignant ovarian epithelial neoplasms.
1975年至1990年间,马萨诸塞州总医院对79例I期上皮性卵巢癌患者进行了治疗。通过肿瘤登记处确定患者,并对病历进行回顾性审查。对病理切片进行评估,以确定是否存在子宫内膜异位症,特别留意子宫内膜异位症中出现的恶性肿瘤。在79例病例中有22例(28%)发现了子宫内膜异位症的证据。在23例子宫内膜样组织学病例中,9例(39%)与子宫内膜异位症有关;在17例透明细胞肿瘤病例中,7例(41%)与子宫内膜异位症有关。所有8例混合组织学病例均有透明细胞和/或子宫内膜样成分,其中4例(50%)与子宫内膜异位症有关。与子宫内膜异位症相关的肿瘤中,子宫内膜样腺癌占41%,透明细胞癌占31%,混合性(子宫内膜样和/或透明细胞类型)占18%,其他类型占9%。在22例伴有子宫内膜异位症的患者中,我们发现7例(32%)癌肿起源于子宫内膜异位症。在这7例病例中,发现了一系列从良性和非典型子宫内膜异位症转变为透明细胞或子宫内膜样腺癌的病变。这些癌前病变的特征是细胞异型性和结构增生。在子宫内膜样和透明细胞组织学类型的I期上皮性卵巢癌患者中,经常会遇到子宫内膜异位症。子宫内膜异位症可能在某些早期恶性卵巢上皮性肿瘤的发病机制中起作用。